Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023

BUY
$0.32 - $1.14 $900 - $3,207
2,814 New
2,814 $0
Q1 2023

Apr 27, 2023

BUY
$0.71 - $2.86 $2,285 - $9,206
3,219 New
3,219 $2,000
Q3 2022

Nov 04, 2022

SELL
$1.52 - $2.57 $349 - $591
-230 Reduced 23.19%
762 $1,000
Q2 2022

Aug 03, 2022

SELL
$2.53 - $4.42 $447 - $782
-177 Reduced 15.14%
992 $2,000
Q1 2022

May 02, 2022

SELL
$3.78 - $4.66 $430 - $531
-114 Reduced 8.89%
1,169 $5,000
Q4 2021

Feb 23, 2022

SELL
$4.12 - $6.35 $82,589 - $127,292
-20,046 Reduced 93.98%
1,283 $5,000
Q2 2021

Aug 12, 2021

BUY
$4.7 - $16.7 $65,428 - $232,480
13,921 Added 187.92%
21,329 $220,000
Q1 2021

Apr 26, 2021

BUY
$3.79 - $9.78 $28,076 - $72,450
7,408 New
7,408 $56,000

About Nemaura Medical Inc.


  • Ticker NMRD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,102,900
  • Description
  • Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...
More about NMRD
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.